Evidence map›Paper›PMID 40409259›Full record

ArticleStem cell reports2025

Cell competition eliminates aneuploid human pluripotent stem cells.

Amanda Ya, Chenhui Deng, Kristina M Godek

Abstract read
In one paragraph

Article in Stem cell reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Amanda YaDepartment of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA; Dartmouth Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
Chenhui DengDepartment of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA; Dartmouth Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
Kristina M GodekDepartment of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA; Dartmouth Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. Electronic address: kristina.m.godek@dartmouth.edu.

Funding

Causes and Consequences of Aneuploidy in HeSCsR01HD101436 · NICHD · DARTMOUTH COLLEGE · PI GODEK, KRISTINA M · 2020 to 2024
$1.7M
NICHD NIH HHS R01 HD101436
6 · The paper itself

Abstract

Human pluripotent stem cells (hPSCs) maintain diploid populations for generations despite frequent mitotic errors that cause aneuploidy or chromosome imbalances. Consequently, aneuploid hPSC propagation must be prevented to sustain genome stability, but how this is achieved is unknown. Surprisingly, we find that, unlike somatic cells, uniformly aneuploid hPSC populations with heterogeneous abnormal karyotypes proliferate. Instead, in mosaic populations, cell-non-autonomous competition between neighboring diploid and aneuploid hPSCs eliminates less fit aneuploid cells, regardless of specific chromosome imbalances. Aneuploid hPSCs with lower MYC or higher p53 levels relative to diploid neighbors are outcompeted but conversely gain an advantage when MYC and p53 relative abundance switches. Thus, MYC- and p53-driven cell competition preserves hPSC genome integrity despite their low mitotic fidelity and intrinsic capacity to proliferate with an aneuploid genome. These findings have important implications for using hPSCs in regenerative medicine and for how diploid human embryos form during development despite the prevalence of aneuploidy.

Indexed as

AneuploidyCell CompetitionPluripotent Stem CellsCell LineCell ProliferationDiploidyHumansProto-Oncogene Proteins c-mycTumor Suppressor Protein p53Proto-Oncogene Proteins c-mycTumor Suppressor Protein p53aneuploidycell competitionhuman pluripotent stem cellsmosaicismMYCp53preimplantation embryos

Identifiers

PMID40409259
PMCPMC12181964

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.